OOIR: Observatory of International Research

Papers

(The TQCC of Expert Review of Gastroenterology & Hepatology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Managing pain in irritable bowel syndrome: current perspectives and best practice	76
Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis	40
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions	29
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors	28
Multidetector computed tomography angiography in non-variceal upper gastrointestinal bleeding: when, why and how?	27
A narrative review on the diagnosis and management of constipation in infants	25
Small bowel transplant – novel indications and recent progress	25
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?	24
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences	23
Targeting liver metabolism: a pathway to cure hepatitis B virus?	23
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)	23
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis	22
High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites	22
Gender-related differences in celiac disease presentation and follow-up in adult patients	22
Irritable bowel syndrome – controversies in diagnosis and management	21
Extra-pancreatic malignancies in patients with intraductal papillary mucinous neoplasms	20
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management	19
Elucidating the role of extracellular vesicles in liver injury induced by HIV	19
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease	19
Therapeutic drug monitoring in inflammatory bowel disease: recent developments	18
The assessment of impaired liver function and prognosis in hepatocellular carcinoma	18
Recent advances in treating constipation in children	18
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction	17
Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities	16
The evolution of irritable bowel syndrome as a group of organic diseases: a narrative review	16

Investigating the correlation between COVID-19 and the progression of chronic liver disease	16
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	15
Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma	15
Small bowel imaging in inflammatory bowel disease: updates for 2023	15
Managing bile acid diarrhea: aspects of contention	15
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice	15
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?	15
Biliary diversion in progressive familial intrahepatic cholestasis: a systematic review and meta-analysis	15
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment	15
Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice	15
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized cont	14
Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract	14
Chronic nausea and vomiting: a diagnostic approach	13
IBD in women of reproductive age: where do novel therapies fit in?	13
Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective	13
To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis	13
Evaluating the role of endoscopic ultrasound in pancreatitis	13
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States	13
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis	13
Psychological distress in inflammatory bowel disease	12
High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysis	12
Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer – a systematic review and meta-analysis	12
Highlights of the drug-induced liver injury literature for 2021	12
Two-dimensional shear wave elastography for sparing endoscopy screening in patients with HBV-related compensated advanced chronic liver disease	12
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives	11
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery	11
Artificial intelligence implementation in pancreaticobiliary endoscopy	11
Carcinoid syndrome mimicking irritable bowel syndrome: don’t fall into the trap	10
Gastroesophageal reflux disease in preterm infants: unmet needs	10
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma	10
Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review	10
Managing pediatric Crohn’s disease: recent insights	10
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays	10
Diagnosing eosinophilic esophagitis in pediatric patients	10
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview	9
Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases	9
Reply to letter to the Editor: Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	9
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece	9
Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults	9
Management of disease-related abdominal abscesses in Crohn’s disease	9
Paraneoplastic syndromes in hepatocellular carcinoma: a review	9
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis	9
Managing complications of chronic pancreatitis: a guide for the gastroenterologist	9
Towards a better diagnosis of gastro esophageal reflux disease	8
Highlighting novel targets in immunotherapy for liver cancer	8
Clinical management of inflammatory bowel disease from preconception to postpartum	8
The TL1A inhibitors in IBD: what’s in the pot?	8
Systematic mapping of worldwide research on intra-pancreatic fat deposition	8
Measuring gut microbiome as a colorectal cancer screening tool: potential and challenges	8
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art	8

The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis	8
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study	8
PSC patient with jaundice – should we ERCP?	8
Characterizing Crohn’s disease phenotypes through pan-enteric capsule endoscopy	8
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation	8
Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment	8
EUS-guided gastro-enteral anastomosis for the treatment of gastric outlet obstruction: is the end of the enteral stent?	8
Acute severe ulcerative colitis: defining the precise moment for colectomy	8
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study	8
Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review	7
Medical management of acute severe ulcerative colitis in the hospitalized patient	7
Endoscopic ultrasound-guided pancreatic duct drainage: a comprehensive state of the art review	7
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights	7
Nutritional aspects of inflammatory bowel disease	7
Introducing the “guideline comparison” article type	7
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity	7
Grayscale ultrasonography findings for characterization of gallbladder wall thickening in non-acute setting: a systematic review and meta-analysis	7
Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review	7
Proton beam therapy in the management of hepatocellular carcinoma	7
Induction and maintenance of healing in erosive esophagitis in the United States	7
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis	7
Endoscopic follow-up in patients with first-degree relatives for gastric cancer: a real-world observational study	7
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma	7
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect	7
Prioritization in inflammatory bowel disease therapy	7
Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan	7
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn’s disease	7
Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis	7
Radiation safety and dose management in fluoroscopy-guided gastrointestinal procedures: current evidence and future perspectives	7
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease	7
Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease	7
Histamine-producing bacteria and their role in gastrointestinal disorders	7
2023 update on the clinical management of gastroparesis	7